Categories: Government agency news release

1 2/22/2018

Potential harms and source of evidence missing in FDA summary of new blood test for concussion


NIH recap on ‘brain disease test’: strong on study results, but lacks clarity on patient benefits


Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?


FDA could do a better job sharing numbers on costly new eczema drug


FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good


FDA announces approval of new psoriasis drug with strong caveats on harms, but no data to support benefit claim


NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

2 1/31/2017

How big is symptom improvement with new constipation drug? Readers might have to strain to find out


Fenofibrate as add-on to statins for type 2 diabetes: NIH release promotes possible benefit found only in small subgroup of patients


FDA release on Intrarosa approval omits important conflict of interest